| Pharmaceutical Information |
| Drug Name |
Propantheline |
| Drug ID |
BADD_D01860 |
| Description |
A muscarinic antagonist used as an antispasmodic, in rhinitis, in urinary incontinence, and in the treatment of ulcers. At high doses it has nicotinic effects resulting in neuromuscular blocking. |
| Indications and Usage |
For the treatment of enuresis. It has also been used for hyperhidrosis, and cramps or spasms of the stomach, intestines or bladder. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
A03AB05 |
| DrugBank ID |
DB00782
|
| KEGG ID |
C07506
|
| MeSH ID |
D011413
|
| PubChem ID |
4934
|
| TTD Drug ID |
D0V5ZZ
|
| NDC Product Code |
Not Available |
| Synonyms |
Propantheline | Propantheline Bromide | Bromide, Propantheline | Probanthine | Pro-Banthine | Pro Banthine |
|
| Chemical Information |
| Molecular Formula |
C23H30NO3+ |
| CAS Registry Number |
298-50-0 |
| SMILES |
CC(C)[N+](C)(CCOC(=O)C1C2=CC=CC=C2OC3=CC=CC=C13)C(C)C |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
